Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | DRD2 | P14416 | 4/20 | 0.61 |
| ▸ | DRD3 | P35462 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16233190 | 1.00 | ABCG2 (0.74) | ABCG2MEN1KMT2ADRD2DRD3 | |
| SCHEMBL16233222 | 0.87 | SLC6A5 (0.57) | ABCG2MEN1KMT2ADRD2DRD3 | |
| SCHEMBL16234612 | 0.84 | ABCG2 (0.80) | ABCG2MEN1KMT2ADRD2DRD3 | |
| SCHEMBL9550028 | 0.83 | DRD2 (0.67) | MEN1KMT2ADRD2DRD3 | |
| SCHEMBL9550023 | 0.83 | DRD2 (0.67) | MEN1KMT2ADRD2DRD3 | |
| SCHEMBL8012031 | 0.82 | ABCG2 (0.76) | ABCG2MEN1KMT2ADRD2DRD3 | |
| SCHEMBL4341169 | 0.79 | MCHR1 (0.69) | ABCG2KMT2ADRD2 | |
| SCHEMBL8009613 | 0.79 | ABCG2 (0.80) | ABCG2MEN1KMT2ADRD2DRD3 | |
| SCHEMBL28546531 | 0.79 | DRD3 (0.60) | ABCG2DRD2DRD3 | |
| SCHEMBL11072498 | 0.78 | DRD2 (0.79) | DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9359346-B2 | Benzamide derivative and use thereof | VIVOZON, INC. (KR) | 2016-06-07 | — | — | US | disclosed |
| US-9359346-B2 | Benzamide derivative and use thereof | VIVOZON, INC. (KR) | 2016-06-07 | — | — | US | disclosed |
| US-20140336378-A1 | NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF | VIVOZON, INC. (KR) | 2014-11-13 | — | — | US | disclosed |
| US-20140336378-A1 | NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF | VIVOZON, INC. (KR) | 2014-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140336378-A1 | NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF | TRPV1, TRPA1, TRPV5 | ABCG2 963/4885MEN1 4781/4885KMT2A 1068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.